**Author Information** An event is serious (based on the ICH definition) when the patient outcome is:\* death\* life-threatening\* hospitalisation\* disability\* congenital anomaly\* other medically important event\* Drug overdose

A 27-year-old man developed hydroxychloroquine poisoning, non-bloody emesis, nausea, diffuse weakness of all four extremities, widened QRS complex and QTc interval, non-sustained ventricular tachycardia, progressive somnolence and hypokalaemia following an overdose of hydroxychloroquine and developed haematologic toxicity following an overdose of methotrexate in a suicide attempt. Additionally, he also received an overdose of prednisone and diazepam \[*not all duration of treatments to reactions onsets and outcomes stated*\].

The man, who had a history of rheumatoid arthritis and untreated depression, presented to emergency department (ED) with non-bloody emesis and nausea. It was reported that around 8 hours prior to presentation, he had an intentional overdose of by ingestion of approximately 20 tablets of hydroxychloroquine 200mg, 30 tablets of methotrexate 2.5mg and 30 tablets of prednisone 10mg. On arrival, his vital signs were as follows: heart rate 63 beats/minute, BP 95/55mm Hg, respiratory rate of 23 breaths/minute, and oxygen saturation 99% on room air. Examination showed 3mm pupils bilaterally without nystagmus. Other examinations were unremarkable. Neurologic examination revealed diffuse weakness of all four extremities. He was somnolent but arousable to voice. On further questioning, he divulged his suicide attempt. Laboratory test at 8 hours after ingestion showed potassium 2.0 mmol/L, WBC count was 11.03 K/μL, haemoglobin was 14.4 g/dL and platelet count was 166 K/μL. Electrocardiogram (ECG) revealed a widened QRS complex of 134ms and a QTc interval of 710ms. At ED, he had several episodes of non-sustained ventricular tachycardia. Additionally, he developed progressive somnolence, QTc prolongation and subsequent episodes of non-sustained ventricular tachycardia.

Subsequently, the man was electively orotracheal intubated using etomidate and suxamethonium chloride \[succinylcholine\]. Laboratory investigation showed undetectable concentrations of acetaminophen and salicylates, while a methotrexate concentration of 0.35 umol/L at 12 hours after ingestion. Hypokalaemia was also noted with the remainder of his electrolytes within normal range. At 24 hours after ingestion potassium was 5.9 mmol/L, WBC count was 9.11 K/μL, haemoglobin was 10.8 g/dL and platelet count was 127 K/μL. Considering widened QRS, prolonged QTc, and hypokalaemia, he was diagnosed with hydroxychloroquine poisoning. His initial findings suggested cardiac conduction abnormalities, hence he was transferred to a tertiary care center for advanced treatment. IV potassium replacement treatment was initiated. Following administration of sodium bicarbonate his QRS improved to a 128ms and QTc to 639ms. After improvement in his cardiac conduction, it was decided to maintain him on a sodium bicarbonate infusion. On arrival to the tertiary care center, he received an IV diazepam bolus of 1 mg/kg over 30 minutes, for approximately 4 hours. Intermittent diazepam boluses were started at 6.5mg every 2 hours, in order to reduced and maintain his QRS under 100ms. He was started on epinephrine, which was eventually discontinued as per hospital protocol as he was able to maintain adequate systolic arterial pressure without need of additional haemodynamic support. He was admitted to the intensive care unit (ICU) for continued management. At the ICU, he was initiated on continuous fentanyl and propofol infusions for sedation and analgesia. His hypokalaemia was treated with potassium chloride. Nineteen hours following the initiation of diazepam treatment, the QRS narrowed to 94ms, while the QTc reduced to 487ms. After a cumulative dose of 124mg over 12 hours, treatment with diazepam was discontinued with ECG showing QRS narrowed to 88ms and QTc reduced to 499ms. The cumulative dosage diazepam included 5mg IV once at the community hospital and 80mg IV bolus with 39mg IV intermittent boluses every 2 hours at tertiary center. Subsequent blood test showed a rapid decrease in haemoglobin and platelet count, which suggested medication-induced haematologic toxicity. He was treated with folinic acid \[leucovorin\] and methotrexate concentrations were monitored, which decreased from 0.35 to 0.15 umol/L. After reduction in methotrexate concentration and stable markers of acute haemolytic processes, treatment with folinic acid was stopped. At 42 hours after ingestion, potassium was 4.6 mmol/L, WBC count was 11.94 K/μL, haemoglobin was 11.4 g/dL and platelet count was 135 K/μL.On extubation, he confirmed his ingestion of hydroxychloroquine as well as methotrexate. Despite receiving monthly refills of hydroxychloroquine and methotrexate by mail, he described non-adherence to both xenobiotics during the COVID-19 pandemic. He had stockpiled these medications and ingested them in whole on the day of presentation to the ED.
